Diseases & Disorders
(G80)
IRS Verified
DX Registered
990 on File
LYMPHOMA RESEARCH FOUNDATION
Financial strength (30%)
77/100
Reliability (20%)
81/100
Effectiveness (25%)
84/100
Impact (25%)
70/100
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$14.2M
Total Revenue
$14.3M
Total Expenses
$34.5M
Net Assets
47
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
71.6%
Fundraising Efficiency
349.3%
Operating Reserve
28.96x
Liability-to-Asset
19.2%
Revenue Diversification
62.8%
Executive Compensation
$1.1M
Compared with Peers
FY 2025
Compared with 77 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
71.6% | 85.3% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
13.0% | 11.8% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
15.4% | 0.8% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
349.3% | 350.6% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
29.0 mo | 9.7 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
19.2% | 20.6% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
62.8% | 92.8% |
P10P90
|
Top quarter |
|
Surplus margin
Surplus as a share of revenue
|
-0.9% | 2.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $14.2M | $14.3M | $34.5M | 71.6% | 47 |
| 2024 | N/A | N/A | N/A | — | — |
| 2023 | $16.6M | $14.0M | $30.3M | 74.6% | 38 |
| 2022 | $14.7M | $12.9M | $27.6M | 78.4% | 34 |
| 2021 | $26.5M | $8.1M | N/A | — | 34 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.